Healthcare provider profile · identity verified

Odis Wayne Gossett, M.D.

Family Practice · NEDERLAND, TX · NPI 1477556322

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	348	93
Pantoprazole Sodium	Pantoprazole Sodium	289	82
Alprazolam	Alprazolam	253	44
Levothyroxine Sodium	Levothyroxine Sodium	230	60
Losartan Potassium	Losartan Potassium	176	51
Atorvastatin Calcium	Atorvastatin Calcium	168	49
Metformin Hcl	Metformin Hcl	162	47
Lisinopril	Lisinopril	159	51
Rosuvastatin Calcium	Rosuvastatin Calcium	146	44
Trazodone Hcl	Trazodone Hcl	144	36
Gabapentin	Gabapentin	142	44
Hydrochlorothiazide	Hydrochlorothiazide	129	40
Simvastatin	Simvastatin	129	31
Tamsulosin Hcl	Tamsulosin Hcl	129	31
Escitalopram Oxalate	Escitalopram Oxalate	116	29
Metoprolol Succinate	Metoprolol Succinate	111	27
Acetaminophen-Codeine	Acetaminophen With Codeine	105	18
Zolpidem Tartrate	Zolpidem Tartrate	105	21
Tizanidine Hcl	Tizanidine Hcl	104	29
Albuterol Sulfate Hfa	Albuterol Sulfate	99	34
Pravastatin Sodium	Pravastatin Sodium	99	26
Omeprazole	Omeprazole	95	30
Furosemide	Furosemide	80	25
Buspirone Hcl	Buspirone Hcl	75	16
Tramadol Hcl	Tramadol Hcl	72	23
Methylprednisolone	Methylprednisolone	66	55
Montelukast Sodium	Montelukast Sodium	61	17
Azithromycin	Azithromycin	58	52
Diazepam	Diazepam	58	14
Ezetimibe	Ezetimibe	55	15
Fluticasone Propionate	Fluticasone Propionate	53	24
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	53	12
Lorazepam	Lorazepam	53	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	53	suppressed
Meloxicam	Meloxicam	49	11
Eliquis	Apixaban	47	suppressed
Allopurinol	Allopurinol	46	15
Clopidogrel	Clopidogrel Bisulfate	46	14
Glipizide Er	Glipizide	45	13
Clonazepam	Clonazepam	41	suppressed
Citalopram Hbr	Citalopram Hydrobromide	39	suppressed
Sucralfate	Sucralfate	38	suppressed
Ramipril	Ramipril	36	suppressed
Celecoxib	Celecoxib	31	13
Olmesartan Medoxomil	Olmesartan Medoxomil	31	suppressed
Synthroid	Levothyroxine Sodium	31	suppressed
Carvedilol	Carvedilol	30	12
Cephalexin	Cephalexin	30	25
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	30	20
Amoxicillin	Amoxicillin	29	25
Glimepiride	Glimepiride	29	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	29	suppressed
Potassium Chloride	Potassium Chloride	29	suppressed
Benazepril Hcl	Benazepril Hcl	28	suppressed
Hydralazine Hcl	Hydralazine Hcl	28	suppressed
Pregabalin	Pregabalin	28	suppressed
Methocarbamol	Methocarbamol	27	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	27	suppressed
Atenolol	Atenolol	26	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	26	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	26	suppressed
Bupropion Xl	Bupropion Hcl	25	suppressed
Clonidine Hcl	Clonidine Hcl	25	suppressed
Ozempic	Semaglutide	25	suppressed
Prednisone	Prednisone	25	22
Calcitonin-Salmon	Calcitonin,salmon,synthetic	23	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	23	suppressed
Sertraline Hcl	Sertraline Hcl	23	11
Januvia	Sitagliptin Phosphate	22	suppressed
Meclizine Hcl	Meclizine Hcl	22	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	22	suppressed
Ondansetron Odt	Ondansetron	22	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	22	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Duloxetine Hcl	Duloxetine Hcl	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	13
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	20	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	20	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Mirtazapine	Mirtazapine	20	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	19	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	18	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Ondansetron Hcl	Ondansetron Hcl	18	suppressed
Testosterone Cypionate	Testosterone Cypionate	18	suppressed
Lansoprazole	Lansoprazole	17	suppressed
Repaglinide	Repaglinide	17	suppressed
Rybelsus	Semaglutide	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Clobetasol Propionate	Clobetasol Propionate	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Nateglinide	Nateglinide	16	suppressed
Warfarin Sodium	Warfarin Sodium	16	suppressed
Carisoprodol	Carisoprodol	15	suppressed
Famotidine	Famotidine	15	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	15	suppressed
Indomethacin	Indomethacin	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	15	15
Temazepam	Temazepam	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Bupropion Hcl	Bupropion Hcl	14	suppressed
Donepezil Hcl	Donepezil Hcl	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	suppressed
Nystatin	Nystatin	14	12
Cyproheptadine Hcl	Cyproheptadine Hcl	13	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Nebivolol Hcl	Nebivolol Hcl	13	suppressed
Sildenafil Citrate	Sildenafil Citrate	13	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	12	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Invokana	Canagliflozin	12	suppressed
Jardiance	Empagliflozin	12	suppressed
Linzess	Linaclotide	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Cefdinir	Cefdinir	11	11
Clindamycin Hcl	Clindamycin Hcl	11	suppressed
Glipizide	Glipizide	11	suppressed
Neomycin-Polymyxin-Hc	Neomycin/Polymyxin B/Hydrocort	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error